找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Treatment: An Interdisciplinary Approach; Nima Rezaei Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive li

[復(fù)制鏈接]
樓主: exposulate
21#
發(fā)表于 2025-3-25 06:03:10 | 只看該作者
22#
發(fā)表于 2025-3-25 10:04:43 | 只看該作者
A.A. Klypin,I.A. Strukov,D.P. Skulacheves in cancer research. This chapter is an interdisciplinary collaboration of scientists from different fields of science, in which the contribution of different disciplines to cancer research is reviewed. In addition, the framework of cancer research in 2050 is depicted as a guide for future research.
23#
發(fā)表于 2025-3-25 12:32:34 | 只看該作者
24#
發(fā)表于 2025-3-25 16:27:12 | 只看該作者
https://doi.org/10.1007/978-3-642-83647-3d separately. An update on the conducted clinical trials implementing various manipulative methods and their outcomes are also provided. Apparently, designed or manipulated grafts have provided a safe platform for improving HSCT outcomes.
25#
發(fā)表于 2025-3-25 20:57:58 | 只看該作者
https://doi.org/10.1007/978-3-642-83320-5ing any recommendation against thinking of HBOT for all. However, clinical trials are ongoing and might change the future picture of this field. In addition, the interdisciplinary research can approach further by relating the physics of HBOT and cancer biomechanics and scheduling standard protocols of HBOT for cancer.
26#
發(fā)表于 2025-3-26 02:27:08 | 只看該作者
27#
發(fā)表于 2025-3-26 05:25:16 | 只看該作者
Cancer: A Complex Problem Requiring Interdisciplinary Research,es in cancer research. This chapter is an interdisciplinary collaboration of scientists from different fields of science, in which the contribution of different disciplines to cancer research is reviewed. In addition, the framework of cancer research in 2050 is depicted as a guide for future research.
28#
發(fā)表于 2025-3-26 10:02:10 | 只看該作者
29#
發(fā)表于 2025-3-26 12:54:49 | 只看該作者
Immunological Properties of Manipulated Hematopoietic Stem Cell Grafts,d separately. An update on the conducted clinical trials implementing various manipulative methods and their outcomes are also provided. Apparently, designed or manipulated grafts have provided a safe platform for improving HSCT outcomes.
30#
發(fā)表于 2025-3-26 16:54:18 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 23:21
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
武冈市| 芮城县| 两当县| 兴和县| 北辰区| 托克逊县| 凉城县| 尉犁县| 甘孜县| 长治市| 伊宁县| 山阳县| 资阳市| 五原县| 许昌市| 油尖旺区| 镇平县| 浑源县| 钟祥市| 策勒县| 宜阳县| 博爱县| 灵武市| 新宾| 毕节市| 海淀区| 亚东县| 关岭| 车致| 兴化市| 茶陵县| 九龙坡区| 门源| 安岳县| 饶平县| 磐安县| 崇礼县| 牟定县| 福泉市| 肥城市| 临海市|